Skip to content

Treating Arteriovenous Malformation With Stereotactic Radiosurgery Using CT Angiography for Treatment Planning

Validation Study of Treating Arteriovenous Malformation With Stereotactic Radiosurgery Using CT Angiography for Treatment Planning

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03559556
Enrollment
14
Registered
2018-06-18
Start date
2019-07-25
Completion date
2024-06-24
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriovenous Malformations

Brief summary

Evaluate whether a treatment plan based on CT angiography can accurately and precisely identify the target nidus as compared to standard cerebral arteriography fused to MRI.

Detailed description

Stereotactic Radiosurgery is a preferable treatment option for patients with Arteriovenous malformation (AVM) that are not surgically accessible or in patients with comorbidities that make them poor surgical candidates At University of Texas Southwestern Medical Center (UTSW), investigator routinely perform interventional cerebral arteriography on the day of the SRS procedure for improved target delineation. Even though the addition of angiography is time consuming and requires multi-modality team care, this approach has allowed UTSW to treat the smallest possible target, yet achieve excellent obliteration rates of AVM with very low toxicity from the procedure. At UTSW the investigator also use CT angiogram at the treatment team's discretion to further enhance the accurate delineation of the final treatment target volume. However, it had not been routinely done due to uncertain benefit in treatment planning and a concern for renal burden from additional intravenous (IV) contrast usage. This prospective enrollment and conduct open-label, retrospective analysis study is to evaluate whether a target volume based on CT angiography can serve as a reliable substitute for a target based on interventional cerebral arteriography. Patients on this protocol will still get treated based on target generated by interventional cerebral arteriography but also receive CT angiography. If the target volume based on CT angiography are adequate compared to their invasive counterpart, future investigators may selectively omit performing interventional cerebral arteriography in the treatment planning for SRS of AVM. Use of CT angiography may lead to reduction in the risk from the procedure and cost, improve the efficiency of the treatment process ideally without compromising the success of the procedure, with greater patient comfort and satisfaction.

Interventions

CT angiography uses a CT scanner to produce detailed images of both blood vessels and tissues in various parts of the body. An iodine-rich contrast material (dye) is usually injected through a small catheter placed in a vein of the arm.

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Masking description

Neurosurgeon who contoured AVM nidus using interventional cerebral arteriography.

Intervention model description

The study proposes to evaluate whether a target volume based on CT angiography can serve as a reliable substitute for a target based on interventional cerebral arteriography. Patients on this protocol will still get treated based on target generated by interventional cerebral arteriography but also receive CT angiography. If the target volume based on CT angiography are adequate compared to their invasive counterpart, future investigators may selectively omit performing interventional cerebral arteriography in the treatment planning for SRS of AVM. Use of CT angiography may lead to reduction in the risk from the procedure and cost, improve the efficiency of the treatment process ideally without compromising the success of the procedure, with greater patient comfort and satisfaction.

Eligibility

Sex/Gender
ALL
Age
10 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

1. Documented AVM with draining vein(s). 2. Adequate renal function (serum Creatinine \< 1.5 mg/dl within 30 days of SRS) to undergo contrast CT and interventional cerebral arteriography on the same day, as determined by treating physicians. 3. AVM must be physically separated from the optic pathway, brainstem or spinal cord. 4. The maximum diameter of AVM nidus must be less than 3.5 cm and/or less than 12 cc. 5. Age ≥ 10 years. 6. All men, as well as women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately 6.1 A female of child-bearing potential is any woman (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria: * Has not undergone a hysterectomy or bilateral oophorectomy; or * Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months). 7. Ability to understand and the willingness to sign a written informed consent.

Exclusion criteria

1. Patients without a documented AVM. 2. Patients with a contraindication to CT or MRI such as contrast allergy, kidney failure or implanted metal devices or foreign bodies or severe claustrophobia. 3. Use of Nephrotoxic drugs, such as gentamycin, high-dose nonsteroidal anti-inflammatory drugs, or certain chemotherapeutic drugs within 10 days of the procedure. 4. Psychiatric illness/social situations that would limit compliance with study requirements. 5. Patients must not be pregnant at the time of SRS treatment.

Design outcomes

Primary

MeasureTime frameDescription
Target Volume Difference Between Standard of Care vs. CT Angiogram and MRI AloneSame day measurementsThe primary endpoint of this study is to compare the volumes of targets generated from interventional cerebral arteriography (reference) to targets generated from CT angiogram and MRI alone, to assess whether noninvasive imaging approaches are noninferior to the UTSW standard

Secondary

MeasureTime frameDescription
CT Angiogram Additional TimeSame dayAdditional time required for CT angiogram after standard of care imaging

Countries

United States

Participant flow

Participants by arm

ArmCount
Patient With AVM Requiring Radiotherapy
Patients who received planning CT angiogram in addition to standard of care CT angiography: CT angiography uses a CT scanner to produce detailed images of both blood vessels and tissues in various parts of the body. An iodine-rich contrast material (dye) is usually injected through a small catheter placed in a vein of the arm.
14
Total14

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicPatient With AVM Requiring Radiotherapy
Age, Categorical
<=18 years
6 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
11 Participants
Region of Enrollment
United States
14 participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 13
other
Total, other adverse events
4 / 13
serious
Total, serious adverse events
0 / 13

Outcome results

Primary

Target Volume Difference Between Standard of Care vs. CT Angiogram and MRI Alone

The primary endpoint of this study is to compare the volumes of targets generated from interventional cerebral arteriography (reference) to targets generated from CT angiogram and MRI alone, to assess whether noninvasive imaging approaches are noninferior to the UTSW standard

Time frame: Same day measurements

Population: Median volume between standard of care target volumes (mL) vs. CT Angiogram in addition to standard of care. Standard of care is considered reference volume

ArmMeasureValue (MEDIAN)Dispersion
CT Angiogram in Addition to Standard of CareTarget Volume Difference Between Standard of Care vs. CT Angiogram and MRI Alone1.1 mLStandard Deviation 2.5
Standard of CareTarget Volume Difference Between Standard of Care vs. CT Angiogram and MRI Alone1.3 mLStandard Deviation 2.4
Secondary

CT Angiogram Additional Time

Additional time required for CT angiogram after standard of care imaging

Time frame: Same day

Population: Time required for CT angiogram

ArmMeasureValue (MEAN)Dispersion
CT Angiogram in Addition to Standard of CareCT Angiogram Additional Time8 MinutesStandard Deviation 4.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026